Has Celine Ow received payments from drug or device companies?

Yes. Drug and device makers reported $2,960 in general payments to Celine Ow across 76 transactions between 2019–2025. Most Open Payments records nationally are meals worth under $20; a reported payment is not evidence of wrongdoing.

Does a payment mean Celine Ow did something wrong?

No. Federal law requires drug and device makers to report almost every transfer of value to a physician, including a $14 sandwich at a lunch presentation. Consulting fees, research funding and royalties to device inventors are ordinary, legal parts of medicine. This site reports what was disclosed; it makes no allegation.

Where does this information about Celine Ow come from?

The U.S. Centers for Medicare & Medicaid Services. Payments come from Open Payments, published under the Physician Payments Sunshine Act. Billing and prescribing figures come from the Medicare Physician & Other Practitioners and Part D Prescriber public use files for 2024.

Celine Ow

Nurse Practitioner · South Miami, FLNPI 1922641976

Payments from drug & device makers

$2,960in general payments, 2019–2025

Across 76 payments — averaging $38.95 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

Edwards Lifesciences$1K
Amgen$286
Medtronic$241
Novo Nordisk$193
AstraZeneca$177
Pfizer$175
plus $670 from 13 others

What the payments were for

Travel & lodging$42914%
Food & beverage$2,40181%
Education$1304%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

Company	Payments	Total
Edwards Lifesciences	12	$1,219
Amgen	5	$286
Medtronic	4	$241
Novo Nordisk	8	$193
AstraZeneca	10	$177
Pfizer	11	$175
Boston Scientific	1	$171
E.r. Squibb & Sons, L.L.C.	5	$103
Kiniksa Pharmaceuticals International, PLC	3	$56
Novartis	3	$55
Kestra Medical Technology Services, Inc.	2	$48
Bayer	2	$42
Kiniksa Pharmaceuticals, Ltd.	2	$42
Lilly USA, LLC	2	$33
Regeneron Healthcare Solutions, Inc.	2	$31
Bridgebio Pharma, Inc.	1	$29
Lexicon Pharmaceuticals, Inc.	1	$24
Alnylam Pharmaceuticals Inc.	1	$21
Boehringer Ingelheim	1	$16

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$2,960 in reported general payments places this provider in the 85th percentile of 8,290 nurse practitioner providers in Florida.

See all nurse practitioner providers in Florida →

Most prescribed under Part D

Drug	Claims	Cost to plans & patients
EliquisApixaban	86	$100,604
EntrestoSacubitril/Valsartan	74	$66,084
Repatha SureclickEvolocumab	35	$29,287
FarxigaDapagliflozin Propanediol	20	$19,612
Sildenafil Citrate	16	$19,557
JardianceEmpagliflozin	18	$18,289
Metoprolol Succinate	133	$1,537
Atorvastatin Calcium	128	$1,247
Bumetanide	28	$828
Nifedipine ErNifedipine	37	$807
Hydralazine Hcl	59	$725
Rosuvastatin Calcium	61	$588
Losartan Potassium	79	$552
ClopidogrelClopidogrel Bisulfate	47	$544
Olmesartan Medoxomil	16	$399

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

Company	Paid to this provider	Part D cost of their drugs
PfizerEliquis	$175	$100,60486 claims
NovartisEntresto	$55	$66,08474 claims
AstraZenecaFarxiga	$177	$19,61220 claims
Boehringer IngelheimJardiance	$16	$18,28918 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 85th percentile of 8,290 nurse practitioner providers in Florida.

Other nurse practitioner in South Miami

Jolanta BaginskiClearwater$494K
Adissa PerezWinter Park$370K
April WessonTampa$342K
Margarita FernandezMiami$311K
Stephanie SimmermanNaples$283K
Claudette WalkerPonte Vedra Beach$271K
Lisa NodzonTampa$246K
Ashima BahlTampa$226K
Maya BloombergMiami$202K
Jennifer PuleoTampa$171K

See the full list for Florida →

Where these figures come from

Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
Identity: NPPES NPI Registry, July 2026.

Is this you, or does something look wrong? →